INSIGHTS ON DRUG DEVELOPMENT

• Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success

  By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.

• Assessing Particle Generation In A Single-Use Mixing System

  Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.

• AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids

  Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.

• Integrating Phase-Appropriate Quality Standards

  Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.

• Comprehensive Workflow For The Quantification Of Peptides And Proteins

  7/29/2025

  Biologics are transforming medicine, with semaglutide leading the way. Discover how an automated LC-MS/MS workflow enables high-sensitivity quantification of peptides in plasma.

• Nose To Brain (N2B) Drug Delivery – Benefits And Challenges

  11/20/2024

  Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).

• The Benefits Of Incorporating Lean Methodologies Into Project Management

  8/20/2024

  Delve into the core principles of lean project management and explore how these principles can be integrated with traditional methods to enhance project outcomes.

• Your Guide To Precise And Robust Separation Methods

  11/12/2025

  Discover a detailed guide to characterizing GLP-1 receptor agonists that covers advanced LC-MS and SEC-MALS workflows for impurity profiling, stability testing, and aggregate analysis.

• Organ-Chips Outperform Animal Models And Spheroids

  8/2/2024

  Examine how 780 human Liver-Chips were assessed for their ability to predict drug-induced liver injury from small molecules.